# The HOPE Study: Characterizing Patients With Hepatitis B and C

> **NCT02995252** · — · RECRUITING · sponsor: **University of Maryland, Baltimore** · enrollment: 550 (estimated)

## Conditions studied

- Hepatitis B， Chronic
- Hepatitis C

## Interventions

- **OTHER:** Blood draws
- **DRUG:** Tenofovir Alafenamide
- **OTHER:** Knowledge Index Questionnaire
- **OTHER:** Liver transient elastography (FibroScan)
- **PROCEDURE:** Liver Biopsy

## Key facts

- **NCT ID:** NCT02995252
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2014-12
- **Primary completion:** 2034-07
- **Final completion:** 2034-12
- **Target enrollment:** 550 (ESTIMATED)
- **Last updated:** 2025-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02995252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02995252, "The HOPE Study: Characterizing Patients With Hepatitis B and C". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02995252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*